RHEACELL Innovative Stem Cell Therapies

WIPO WIPO 2020

Schützen Sie diese Marke vor Nachahmern!

Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.

Die Internationale Marke RHEACELL Innovative Stem Cell Therapies wurde als Wortmarke am 11.12.2020 bei der Weltorganisation für geistiges Eigentum angemeldet.

Markendetails Letztes Update: 31. August 2022

Markenform Wortmarke
Aktenzeichen 1581960
Registernummer 302020013149
Länder Australien Kanada Europäische Gemeinschaft Großbritannien Vereinigte Staaten von Amerika (USA) Schweiz China Russland Vietnam
Basismarke DE Nr. 30 2020 013 149, 10. November 2020
Anmeldedatum 11. Dezember 2020
Ablaufdatum 11. Dezember 2030

Markeninhaber

Im Neuenheimerfeld 517
69120 Heidelberg
DE

Markenvertreter

Schreiberstr. 20 79098 Freiburg DE

Waren und Dienstleistungen

05 Drugs; pharmaceutical and veterinary preparations; diagnostic agents; pharmaceutical preparations; preparations for medical purposes; preparations for biomedical purposes; pharmaceutical cell preparations for medical use; substances for medical use; substances for biomedical purposes; live implants for pharmaceutical purposes; biochemical and chemical products for medical use; biochemical and chemical products for pharmaceutical purposes; biochemical and chemical products for diagnostic purposes; proteins for medical purposes; biological preparations for medical and veterinary purposes, and pharmaceutical and veterinary preparations, all for external use; biological, pharmaceutical and veterinary preparations for skin care for medical purposes; medical dressings; preparations for wound treating and healing; biological, pharmaceutical and veterinary preparations for the treatment of chronic wounds, ulcers, burns and surgical wounds; stem cells for medical purposes; stern cells for veterinary purposes; stern cells for aesthetic purposes; somatic stem cell therapeutics; fibroblasts for medical purposes; fibroblasts for aesthetic purposes; pharmaceutical implants; surgical implants derived from stem cells; surgical implants derived from fibroblasts; biological tissue for implantation; growth media for culturing cells for medical purposes; pharmaceutical preparations for tissue regeneration; vascular grafts; living tissue; biotechnologically engineered tissue products
42 Pharmaceutical drug development; scientific and technological services; research and development services in the fields of cell diagnostics and therapy and surgical and medical instruments; industrial analysis and research services; scientific research for medical purposes; stem cell research; scientific and medical research and development; scientific research, testing and analysis services; scientific research for medical purposes; medical research; research in the field of biotechnology; research in the field of gene therapy; research and development in the field of immunology; research and development in the field of antibodies; research and development in the field of antibody technology; research and development in the field of bacteriology; research and development in the field of gene expression systems; research and development in the field of vaccines; research and development services for the pharmaceutical industry research and development services in the field of biotechnology
44 Medical services; medical diagnostic services {carrying out tests and analyses]; medical assistance; clinic services; hospital services; plastic and cosmetic surgery; medical therapies; medical services relating to the removal, treatment, processing and storage of human cells and tissue, stem cells and bone marrow, also in the field of regenerative medicine, including tissue engineering; medical services in connection with the removal, treatment, processing and storage of human tissue and stem cells, also in the field of regenerative medicine, including tissue engineering; medical services relating to the cultivation and procurement of stem cells; medical services in connection with the cultivation and procurement of stem cells
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen

Markenhistorie

Datum Belegnummer Bereich Eintrag
26. August 2022 2022/35 Gaz US RAW: Rule 18ter(2)(ii) GP following a provisional refusal
27. Juli 2022 2022/30 Gaz Korrektur
19. Juli 2022 2022/29 Gaz CA Ablehnung
07. März 2022 2022/10 Gaz RU RAW: Rule 18ter(2)(ii) GP following a provisional refusal
22. Februar 2022 2022/8 Gaz CH Ablehnung
18. August 2021 2021/33 Gaz GB Ablehnung
10. August 2021 2021/32 Gaz EM Ablehnung
02. August 2021 2021/31 Gaz RU Ablehnung
15. Juli 2021 2021/30 Gaz CN Ablehnung
09. Juni 2021 2021/23 Gaz AU Ablehnung
09. Juni 2021 2021/23 Gaz US Ablehnung
11. Dezember 2020 2021/9 Gaz DE Eintragung

ID: 141581960